DP
Senior Associate
MH
Investor Relations & Capital Formation Senior...
BR
Managing Partner
Get the full picture
Sign in to uncover key details.
Global BioAccess Fund
Finance · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
880 3rd Ave, New York, New York, 10022, ...Website
www.globalbioaccess.comRevenue
<$5 MillionIndustry
About Global BioAccess Fund
RM Global BioAccess Fund is an investment banking firm that focuses on fund management, specifically investing in transformative technologies aimed at addressing unmet medical needs in oncology, cardiovascular, CNS, and rare diseases. The firm partners with innovative companies to develop novel therapeutics and devices, providing capital to early-stage companies for IND submissions and clinical trials. Their investment strategy is centered on accelerating the development of new medicines to improve patient outcomes. The intended clients include companies in the healthcare sector that are working on groundbreaking medical solutions.Explore more
Global BioAccess Fund Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Global BioAccess Fund
Compare insights from companies similar to Global BioAccess Fund, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Global BioAccess Fund Tech Stack
A closer look at the technologies used by Global BioAccess Fund
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Global BioAccess Fund
Sign Up For FreeTo access detailed company insights
RM Global BioAccess Fund is an investment banking firm that focuses on fund management, specifically investing in transformative technologies aimed at addressing unmet medical needs in oncology, cardiovascular, CNS, and rare diseases. The firm partners with innovative companies to develop novel therapeutics and devices, providing capital to early-s... Read More
